ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

As Mail Order Pharmacies Continue to Climb in Customer Satisfaction, Chain Drug Stores Fall Behind, J.D. Power Finds

Long Wait Times, Issues Filling Prescriptions and Trust Emerge as Top Challenges Confronting Traditional Retail Pharmacies

The level of trust and reliability pharmacy customers have come to expect from their local pharmacist is increasingly being found instead through mail order pharmacies. According to the J.D. Power 2024 U.S. Pharmacy Study,SM released today, overall satisfaction with mail order pharmacies is rising steadily, with a 6-point increase (on a 1,000-point scale) in overall customer satisfaction this year. Meanwhile, chain drug stores have seen their overall satisfaction scores slide far below the brick-and-mortar category average, with long wait times, lower levels of customer trust in pharmacists and difficulty in ordering prescriptions emerging as problem areas for the segment.

“The critical link that may allow brick-and-mortar pharmacies to keep pace with the rise of mail order and digital pharmacies is the familiarity that customers have with their pharmacist,” said Christopher Lis, managing director of global healthcare intelligence at J.D. Power. “This is a big differentiator that brick-and-mortar pharmacies need to closely monitor, as 52% of customers are now aware of digital pharmacies, most notably, Amazon Pharmacy. Customers need pharmacies to deliver on convenience, reliability and trust—and mail order and digital pharmacies are working to meet those expectations. As more consumers become aware of digital pharmacies, understand how they work and determine that many accept their insurance, brick-and-mortar stores risk losing market share.”

Following are some of the key findings of the 2024 study:

  • Brick-and-mortar pharmacies lose ground to mail order: Even the top-performing brick-and-mortar pharmacies saw overall satisfaction scores decline more than 10 points this year, while satisfaction scores for mail order pharmacies have increased 6 points, on average. The declines in brick-and-mortar chain drug store satisfaction are affected by a combination of long wait times and difficulty ordering prescriptions.
  • Retail pharmacists excel on communication but do not foster trust: Brick-and-mortar pharmacies are excelling in pharmacists’ communication with customers, with 89% of them indicating that their pharmacist’s explanation was understood—a significant positive change from 2023. That said, just 51% say prescriptions were filled quickly, and only 51% say their pharmacist is trustworthy.
  • Online pharmacies need to prioritize ease of use on digital channels: Ease of ordering prescriptions continues to be the top factor driving customer satisfaction with mail order pharmacies. However, just 18% of mail order customers say their pharmacy offers a well-designed digital experience, indicating mail order pharmacies are losing ground on providing a digital experience that meets customers’ expectations.
  • Confusion over insurance still a big obstacle for digital pharmacies: Nearly half (48%) of brick-and-mortar customers say they have not heard of digital pharmacies and just 60% of mail order customers say they have heard of digital pharmacies. The biggest barriers to adoption of digital pharmacies that customers cite are confusion as to whether they would work with their current insurance, trustworthiness and lack of use among people they know.

Study Rankings

Good Neighbor Pharmacy ranks highest among brick-and-mortar chain drug store pharmacies for an eighth consecutive year, with a score of 775. Health Mart (729) ranks second and Rite Aid Pharmacy ranks third (650).

Sam’s Club ranks highest among brick-and-mortar mass merchandiser pharmacies for a ninth consecutive year, with a score of 777. Costco (740) ranks second.

Publix ranks highest among brick-and-mortar supermarket pharmacies with a score of 755. ShopRite (747) ranks second and H-E-B (745) ranks third.

PillPack by Amazon Pharmacy ranks highest in the mail order segment with a score of 759. Amazon Pharmacy (727) ranks second and Kaiser Permanente (726) ranks third.

See the rank chart for each segment at http://www.jdpower.com/pr-id/2024074.

The U.S. Pharmacy Study, now in its 16th year, measures customer satisfaction with brick-and-mortar and mail order pharmacies. The 2024 study is based on responses from 13,505 pharmacy customers who filled a prescription within the past 12 months and was fielded from September 2023 through May 2024.

For more information about the U.S. Pharmacy Study, visit https://www.jdpower.com/business/healthcare/pharmacy-study.

About J.D. Power

J.D. Power is a global leader in consumer insights, advisory services, and data and analytics. A pioneer in the use of big data, artificial intelligence (AI) and algorithmic modeling capabilities to understand consumer behavior, J.D. Power has been delivering incisive industry intelligence on customer interactions with brands and products for more than 55 years. The world's leading businesses across major industries rely on J.D. Power to guide their customer-facing strategies.

J.D. Power has offices in North America, Europe and Asia Pacific. To learn more about the company's business offerings, visit JDPower.com/business. The J.D. Power auto-shopping tool can be found at JDPower.com.

About J.D. Power and Advertising/Promotional Rules: www.jdpower.com/business/about-us/press-release-info

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.